Author Archives: cnorton

BMBL 6th edition

Electronic pdf now available on CDC and NIH (safety) website Electronic version is 508 compliant Hard copy versions will be available beginning December 1st CDC INFO On-Demand – PublicationsEnter the publication ID (300859) NIH is providing an email box for … Continue reading

Posted in Announcements, Documents, NIH | Leave a comment

Opportunity from BIONET (ABSA affiliate)

questions email DAVIDH@LJI.ORG to register ($10 for non BIONET members – BIONETSAFETY.ORG

Posted in Uncategorized | Leave a comment

NIH Guideline Updates

April 25, 2019, the National Institutes of Health (NIH) finalized a proposal to amend the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines) to streamline the oversight of gene therapy research. This proposal, which was … Continue reading

Posted in Uncategorized | Leave a comment

ABSA Risk Group Database App

Risk Group Database App FREE for iTunes and Android! ABSA International created an app for the ABSA Risk Group Database, which is available for Apple and Android devices. The app will allow users to access the ABSA Risk Group Database … Continue reading

Posted in Announcements | Leave a comment

Everett Hanel, Jr. Presidential Award

Biosafety director earns acclaim for securing research pathogens | SOURCE <style> .wpb_animate_when_almost_visible { opacity: 1; }</style> The Colorado State University officer charged with protecting researchers and the public from infectious research pathogens has received international honors for effective safeguards that … Continue reading

Posted in Announcements | Tagged , , | Leave a comment

HHS selects nine regional Ebola and other special pathogen treatment centers

http://www.hhs.gov/news/press/2015pres/06/20150612b.html HHS selects nine regional Ebola and other special pathogen treatment centers • Colorado Department of Public Health and Environment in partnership with Denver Health Medical Center in Denver, Colorado

Posted in Uncategorized | Leave a comment